Extra-genital congenital anomalies are often present in cases of hypospadias, but it is unclear whether they have an association with the outcome of hypospadias surgery. The aim of this study was to review all hypospadias cases that had surgery between 2009 and 2015 at a single centre and identify clinical determinants of the surgical outcome. An extra-genital congenital anomaly was reported in 139 (22%) boys and 62 (10%) had more than 1 anomaly. Of the 626 boys, 54 (9%), including 44 with proximal hypospadias, had endocrine as well as limited genetic evaluation. Of these, 10 (19%) had a biochemical evidence of hypogonadism and 5 (9%) had a molecular genetic abnormality. At least 1 complication was reported in 167 (27%) patients, with 20% of complications (most frequently fistula) occurring after 2 years of surgery. The severity of hypospadias and the existence of other anomalies were clinical factors that were independently associated with an increased risk of complications (p < 0.001). In conclusion, complications following surgery are more likely in those cases that are proximal or who have additional extra-genital anomalies. To understand the biological basis of these complications, there is a greater need to understand the aetiology of such cases.

1.
Ahmed SF, Khwaja O, Hughes IA: The role of a clinical score in the assessment of ambiguous genitalia. BJU Int 85:120-124 (2000).
2.
Ahmed SF, Dobbie R, Finlayson A, Gilbert J, Youngson G, et al: Prevalence of hypospadias and other genital anomalies among singleton births, 1988-1997, in Scotland. Arch Dis Child Fetal Neonatal Ed 89:F149-F151 (2004).
3.
Ahmed SF, Achermann JC, Arlt W, Balen A, Conway G, et al: Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015). Clin Endocrinol(Oxf). 84:771-788 (2016).
4.
Alhomaidah D, McGowan R, Ahmed S: The current state of diagnostic genetics for conditions affecting sex development. Clin Genet 91:157-162 (2017).
5.
Bashamboo A, Eozenou C, Rojo S, McElreavey K: Anomalies in human sex determination provide unique insights into the complex genetic interactions of early gonad development. Clin Genet 91:143-156 (2017).
6.
Bouty A, Ayers KL, Pask A, Heloury Y, Sinclair AH: The genetic and environmental factors underlying hypospadias. Sex Dev 9:239-259 (2015).
7.
Cox K, Bryce J, Jiang J, Rodie M, Sinnott R, et al: Novel associations in disorders of sex development: findings from the I-DSD Registry. J Clin Endocrinol Metab 99:E348-E355 (2014).
8.
Cox K, Kyriakou A, Amjad B, O'Toole S, Flett ME, et al: Shorter anogenital and anoscrotal distances correlate with the severity of hypospadias: a prospective study. J Pediatr Urol 13:57.e1-e5 (2017).
9.
Fernandez N, Escobar R, Zarante I: Craniofacial anomalies associated with hypospadias. Description of a hospital based population in South America. Int Braz J Urol 42:793-797 (2016).
10.
Kourime M, Bryce J, Jiang J, Nixon R, Rodie M, Ahmed S: An assessment of the quality of the I-DSD and the I-CAH registries-international registries for rare conditions affecting sex development. Orphanet J Rare Dis 12:56 (2017).
11.
Lee OT, Durbin-Johnson B, Kurzrock EA: Predictors of secondary surgery after hypospadias repair: a population based analysis of 5,000 patients. J Urol 190:251-256 (2013).
12.
Lucas-Herald A, Bertelloni S, Juul A, Bryce J, Jiang J, et al: The long-term outcome of boys with partial androgen insensitivity syndrome and a mutation in the androgen receptor gene. J Clin Endocrinol Metab 101:3959-3967 (2016).
13.
Lu YC, Huang WY, Chen YF, Chang HC, Pong YH, et al: Factors associated with reoperation in hypospadias surgery - A nationwide, population-based study. Asian J Surg 40:116-122 (2017).
14.
Nissen KB, Udesen A, Garne E: Hypospadias: prevalence, birthweight and associated major congenital anomalies. Cong Anomalies 55:37-41 (2015).
15.
Nixon R, Cerqueira V, Kyriakou A, Lucas-Herald A, McNeilly J, et al: Prevalence of endocrine and genetic abnormalities in boys evaluated systematically for a disorder of sex development. Hum Reprod 32:2130-2137 (2017).
16.
Nordenvall AS, Frisén L, Nordenström A, Lichtenstein P, Nordenskjöld A: Population based nationwide study of hypospadias in Sweden, 1973 to 2009: incidence and risk factors. J Urol 191:783-789 (2014).
17.
Poyrazoglu S, Darendeliler F, Ahmed SF, Hughes I, Bryce J, et al: Birth weight in different etiologies of disorders of sex development. J Clin Endocrinol Metab 102:1044-1050 (2017).
18.
Rodie M, McGowan R, Mayo A, Midgley P, Driver CP, et al: Factors that influence the decision to perform a karyotype in suspected disorders of sex development: lessons from the Scottish Genital Anomaly Network Register. Sex Dev 5:103-108 (2011).
19.
Schneuer FJ, Holland AJ, Pereira G, Bower C, Nassar N: Prevalence, repairs and complications of hypospadias: an Australian population-based study. Arch Dis Child 100:1038-1043 (2015).
20.
Snodgrass W, Villanueva C, Bush NC: Duration of follow-up to diagnose hypospadias urethroplasty complications. J Pediatr Urol 10:208-211 (2014).
21.
Spinoit AF, Poelaert F, Groen LA, Van Laecke E, Hoebeke P: Hypospadias repair at a tertiary care center: long-term follow-up is mandatory to determine the real complication rate. J Urol 189:2276-2281 (2013).
22.
Stojanovic B, Bizic M, Majstorovic M, Kojovic V, Djordjevic M: Penile curvature incidence in hypospadias: can it be determined? Adv Urol Article 2011:813205 (2011).
23.
Swartz JM, Ciarlo R, Denhoff E, Abrha A, Diamond DA, et al: Variation in the clinical and genetic evaluation of undervirilized boys with bifid scrotum and hypospadias. J Pediatr Urol 13:293.e1-293.e6 (2017).
24.
van der Zanden LF, van Rooij IA, Feitz WF, Franke B, Knoers NV, Roeleveld N: Aetiology of hypospadias: a systematic review of genes and environment. Hum Reprod Update 18:260-683 (2012).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.